Impact of Previous Treatments on the Efficacy of Imetelstat in Patients with Transfusion-Dependent, ESA-Relapsed or -Refractory/-Ineligible Lower-Risk Myelodysplastic Syndromes

• By

• Rami S. Komrokji

• Valeria Santini

• Amer M. Zeidan

• Mikkael A. Sekeres

• Pierre Fenaux

• Azra Raza

• Moshe Mittelman

• Sylvain Thépot

• Rena Buckstein

• Ulrich Germing

• Yazan F. Madanat

• María Díez-Campelo

• David Valcárcel

• Anna Jonášová

• Souria Dougherty

• Sheetal Shah

• Qi Xia

• Libo Sun

• Shyamala Navada

• Faye Feller

• Michael R. Savona

• Uwe Platzbecker

• December 31, 2025

• Blood Cancer Journal